Autologous Blood Products

Autologous blood products have created a growing interest for use in a number of therapies.The aim of technologies like ACP (Autologous Conditioned Plasma) is to provide a method of providing concentrated levels of beneficial growth factors for use at the point of care.

In the IRAP II, monocytes (a type of white blood cell) bind to the glass beads. The cells are then stimulated to produce regenerative and anti-inflammatory proteins without the addition of drugs. This process takes place over an incubation period of 24 hours. IRAP II is used to treat mild to moderate osteoarthritis.

View More

Autologous blood products have created a growing interest for use in a number of therapies.The aim of technologies like ACP (Autologous Conditioned Plasma) is to provide a method of providing concentrated levels of beneficial growth factors for use at the point of care.

In the IRAP II, monocytes (a type of white blood cell) bind to the glass beads. The cells are then stimulated to produce regenerative and anti-inflammatory proteins without the addition of drugs. This process takes place over an incubation period of 24 hours. IRAP II is used to treat mild to moderate osteoarthritis.

View More
ACP Max™ Platelet Rich-Plasma (PRP)
ACP Max™ Platelet Rich-Plasma (PRP)
The ACP Max device is a closed, buffy-coat system used to facilitate the safe and rapid preparation of autologous PRP from a sample of the patient's own blood.
Arthrex ACP<sup>®</sup> Double-Syringe System
Arthrex ACP® Double-Syringe System
The Arthrex ACP double-syringe system is used to facilitate the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient’s point of care. The PRP can be mixed with autograft and allograft bone prior to application to an orthopedic surgical site as deemed necessary by the clinical use requirements. There has been increased interest in autologous blood products for use in a number of orthopedic therapies.
Arthrex Angel<sup>®</sup> System
Arthrex Angel® System
Technology is what sets the Angel system apart from the competition. The Angel system uses a proprietary platelet sensor and 1-button automation to prepare customized platelet-rich plasma (PRP) formulations. The Angel system is the only PRP device that can deliver platelet concentrations up to 18x baseline, with adjustable leukocyte concentrations.
IRAP II™ System
IRAP II™ System
Defects in articular cartilage can induce osteoarthritis by causing molecular changes in the synovial fluid. Research in molecular biology discovered the major inducer of osteoarthritis was the general inflammatory cytokine interleukin-1 (IL-1) which plays a key role in accelerating tissue destruction and the repair mechanisms.
IRAP ProEAS™ System
IRAP ProEAS™ System
Defects in articular cartilage can induce osteoarthritis by causing molecular changes in the synovial fluid. Research in molecular biology discovered the major inducer of osteoarthritis was the general inflammatory cytokine interleukin-1 (IL-1), which plays a key role in accelerating tissue destruction and the repair mechanisms.
Thrombinator™ System
Thrombinator™ System
The Thrombinator system is designed to produce autologous serum at the point of care. This autologous serum helps improve the handling of graft tissue hydrated with platelet-rich plasma or bone marrow aspirate by activating the clotting cascade to produce a gel that serves as a binding agent for graft tissue material. The Thrombinator process applies the principles of the clotting cascade to produce autologous serum without the use of harsh chemical reagents.
Viscous-Gel™ and Viscous-Spray™ Delivery Systems
Viscous-Gel™ and Viscous-Spray™ Delivery Systems
The Viscous-Gel high viscosity applicator and Viscous-Spray low viscosity applicator are used to facilitate mixing and delivery of ACP to create an activated gel or spray.
How can we help you?
‌‌‌
Connect With Us
‌
‌‌‌‌‌‌‌
‌
‌
‌
‌
‌
‌
© 2024 Arthrex, Inc. All rights reserved.
‌